Valuation : Celltrion Pharm, Inc.

Market Cap 4,674B 6,294,188B 4,022B 3,784B 3,457B 6,466B 441,269B 6,484B 44,713B 17,351B 226,402B 17,550B 17,167B 729,361B P/E 2019
166x
P/E 2020 417x
Enterprise Value 4,837B 6,514,074B 4,162B 3,916B 3,577B 6,692B 456,685B 6,710B 46,275B 17,957B 234,311B 18,163B 17,767B 754,841B EV / Sales 2019
9.06x
EV / Sales 2020 38x
Free-Float
44.28%
Yield 2019 *
-
Yield 2020 -
1 week-4.11%
Current month-2.04%
1 month-2.04%
3 months-10.81%
6 months-29.20%
Current year-29.57%
1 week 40,650
Extreme 40650
42,200
1 month 40,000
Extreme 40000
47,000
Current year 37,000
Extreme 37000
78,300
1 year 37,000
Extreme 37000
78,300
3 years 37,000
Extreme 37000
124,463.12
5 years 37,000
Extreme 37000
138,792.87
10 years 13,660.97
Extreme 13660.974887
221,035.48
Manager TitleAgeSince
Chief Executive Officer 61 26/03/2024
Director of Finance/CFO 53 -
Sales & Marketing 55 -
Director TitleAgeSince
Chairman 68 28/03/2025
Chairman 42 26/03/2024
Director/Board Member 61 26/03/2024
Date Insider Type Main position Quantity % Market Cap. Importance
07/05/25 Others 24 0.0001%
07/05/25 Others 127 0.0003%
07/05/25 Exercice 4,500 0.0103%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-4.11%-20.48%-32.74% 1.34B
-0.89%-1.09%+20.02%+71.25% 48.26B
-1.72%-1.15%+47.28%+115.51% 40.5B
-2.01%-5.96%+10.68%+80.50% 11.83B
-0.70%-2.70%-12.22%+11.80% 11.85B
+0.57%-0.56%+26.56%+154.33% 9.36B
-1.67%-0.35%+41.04%-12.04% 7.37B
+0.08%-4.11%+22.91%+43.56% 7.5B
-0.89%-3.09%+22.42%+220.05% 7.28B
-0.16%-2.36%-42.27%+15.39% 5.19B
Average -0.74%-2.11%+11.59%+66.76% 15.05B
Weighted average by Cap. -1.05%-1.72%+23.27%+83.27%

Financials

2019 2020
Net sales 174B 233,675B 149B 140B 128B 240B 16,382B 241B 1,660B 644B 8,405B 652B 637B 27,078B 234B 314,554B 201B 189B 173B 323B 22,053B 324B 2,235B 867B 11,314B 877B 858B 36,450B
Net income 8.6B 11,585B 7.4B 6.96B 6.36B 11.9B 812B 11.93B 82.3B 31.93B 417B 32.3B 31.6B 1,342B 20.94B 28,200B 18.02B 16.95B 15.49B 28.97B 1,977B 29.05B 200B 77.74B 1,014B 78.63B 76.92B 3,268B
Net Debt 149B 200,061B 128B 120B 110B 206B 14,026B 206B 1,421B 551B 7,196B 558B 546B 23,183B 163B 219,886B 140B 132B 121B 226B 15,416B 227B 1,562B 606B 7,909B 613B 600B 25,480B
Logo Celltrion Pharm, Inc.
Celltrion Pharm Inc is a Korea-based company engaged in the manufacture and sale of pharmaceuticals. The Company’s products include hepatotonics, analgesics, antipyretics, anti-inflammatory drugs, antihistamines, respiratory apparatus drugs, circularly system drugs, digestives and stomachic drugs, hormone disease drugs, antibiotics, nutrients, tonics, and other drugs. It also provides ethical drugs and over-the-counter (OTC) drugs. The Company distributes its products in domestic market and overseas markets such as Philippines, Kazakhstan, Cambodia and other Southeast Asia countries.
Employees
328
Date Price Change Volume
04/09/26 ₩40,850.00 0.00% 47,726
03/09/26 ₩40,850.00 -0.73% 53,601
02/09/26 ₩41,150.00 -0.96% 77,116
01/09/26 ₩41,550.00 -0.36% 61,490
31/08/26 ₩41,700.00 -2.11% 98,719
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
B
  1. Stock Market
  2. Stocks
  3. A068760 Stock